Aller au contenu principal
Profil bibliographique

Zhengchun Liu

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

27Publications signalées
248Citations signalées
3Affiliations récentes

Les institutions déclarées

Les domaines associés

Bladder and Urothelial Cancer TreatmentsHead and Neck Cancer StudiesFerroptosis and cancer prognosisEpigenetics and DNA MethylationCancer-related molecular mechanisms research

Les publications récentes

Accès ouvert 2026 article OpenAlex

Epigenetic therapy combined with radiotherapy reshapes tumor immune response

Jianing Wang, Junbao Xu, Xiaoqing Ma, Qianqian Wang et autres

Radiotherapy is essential for local tumor control, and increasing evidence highlights its ability to trigger systemic immune responses. However, the integration of this systemic activation into clinical treatment regimens remains limited. The immunosuppressive environment in the tumor microenvironment (TME) is a key …

cn (code pays fourni par la source)

2 citations Experimental and Molecular Pathology
Accès ouvert 2026 article OpenAlex

Knockout of Mucin 1 inhibits the proliferation, migration, and invasion of human MDA-MB-231 cells by blocking autophagy flow

Zhimei Huang, Jiayao Zhao, Qinqin Zhang, Yu Luo et autres

To investigate the effects of Mucin 1 (MUC1) in human triple-negative breast cancer MDA-MB-231cells, the MDA-MB-231 cell line with MUC1 knockout (231-MUC1-KO) was constructed by CRISPR/Cas9 gene editing. Cell proliferation was evaluated using EDU and colony formation assays, and cell migration and …

cn (code pays fourni par la source)

1 citation Brazilian Journal of Medical and Biological Research
Accès ouvert 2025 article OpenAlex

Integrative human pan-cancer analysis of NDC80

Zhengchun Liu, Jianing Wang, Peizhen Geng, Yuan Yuan et autres

Abstract Background NDC80 is pivotal in cell division, particularly in regulating the G2/M transition and mitotic progression. Recent studies have demonstrated that NDC80 is significantly overexpressed in multiple solid tumors. Further analysis has suggested that its high expression is significantly associated with …

cn (code pays fourni par la source)

1 citation Oncology and Translational Medicine
2025 article OpenAlex

Adjuvant apatinib following concurrent chemoradiotherapy in high-risk nasopharyngeal carcinoma: A multicenter, prospective, phase 2 study.

Wei Jiang, Bin Zhang, Yixin Su, Jiän Zhang et autres

e18019 Background: Nasopharyngeal carcinoma (NPC) patients with T4 or N2–3 or lymph node >3cm diseases have a high risk of metastasis. This study aimed to evaluate the efficacy and safety of adjuvant apatinib in high-risk NPC. Methods: This open-label randomized clinical trial …

cn (code pays fourni par la source)

0 citations Journal of Clinical Oncology
Accès ouvert 2024 article OpenAlex

Fuji apple (Malus domestica Borkh. cv. Red Fuji) pomace extracts as a source of antimicrobial and antioxidant polyphenols

Jiankang Wang, Zhengchun Liu, Lina Wei, Changyan Shao et autres

This study aimed to assess the antibacterial and antioxidant properties of both crude polyphenol extract (CPE) and purified polyphenol extract (PPE) obtained from Fuji apple pomace. The antibacterial capacity of both extracts against Staphylococcus aureus was investigated by evaluating the inhibition zones, …

cn (code pays fourni par la source)

0 citations Journal of Food Bioactives
Accès ouvert 2024 article OpenAlex

Induction Chemotherapy Followed by Radiotherapy vs Chemoradiotherapy in Nasopharyngeal Carcinoma

Jinxuan Dai, Bin Zhang, Yixin Su, Yufei Pan et autres

Importance: Induction chemotherapy plus concurrent chemoradiotherapy is recommended for locoregionally advanced nasopharyngeal carcinoma but is associated with higher rates of acute toxic effects and low compliance. Evidence on de-escalating treatment intensity after induction chemotherapy is limited. Objective: To assess if radiotherapy was …

cn (code pays fourni par la source)

43 citations JAMA Oncology
Accès ouvert 2024 article OpenAlex

Apatinib combined with camrelizumab in the treatment of recurrent/metastatic nasopharyngeal carcinoma: a prospective multicenter phase II study

Yunyan Mo, Yufei Pan, Bin Zhang, Jian Zhang et autres

Background: Preclinical studies demonstrated that immune checkpoint inhibitors combined with antiangiogenic drugs have a synergistic anti-tumor effect. This present phase II trial aimed to evaluate the efficacy and safety of apatinib combined with camrelizumab in patients with recurrent/metastatic nasopharyngeal carcinoma (RM-NPC). Methods: …

cn (code pays fourni par la source)

9 citations Frontiers in Immunology
Accès ouvert 2023 article OpenAlex

Novel chimeric antigen receptor T cell-based immunotherapy: a perspective for triple-negative breast cancer

Peizhen Geng, Yuhua Chi, Yuan Yuan, Maoquan Yang et autres

Triple-negative breast cancer (TNBC) is highly aggressive and does not express estrogen receptor (ER), progesterone (PR), or human epidermal growth factor receptor 2 (HER2). It has a poor prognosis, and traditional endocrine and anti-HER2 targeted therapies have low efficacy against it. In …

cn (code pays fourni par la source)

16 citations Frontiers in Cell and Developmental Biology
2022 conference-abstract OpenAlex

Camrelizumab plus apatinib in patients with recurrent and/or metastatic nasopharyngeal carcinoma: A single-arm, multicenter, phase 2 trail.

Yunyan Mo, Yufei Pan, Bin Zhang, Jian Zhang et autres

e18025 Background: Our previous study demonstrated that apatinib has preliminary clinical benefit in recurrent and/or metastatic nasopharyngeal carcinoma (RM-NPC). Preclinical studies showed the combination of immune checkpoint inhibitors and antiangiogenic drugs produces a synergistic effect in anti-tumor activity. This phase 2 trail …

cn (code pays fourni par la source)

0 citations Journal of Clinical Oncology
Accès ouvert 2021 article OpenAlex

Loosening Neuro-Optic Structures Dosimetric Constraints Provides High 5-Year Local Recurrence-Free Survival With Acceptable Toxicity in T4 Nasopharyngeal Carcinoma Patients Treated With Intensity-Modulated Radiotherapy

Tingting Zhang, Meng Michelle Xu, Jinglin Mi, Hui Yang et autres

OBJECTIVE: Whether the original dosimetric constraints of neuro-optic structures (NOS) are appropriate for patients with nasopharyngeal carcinoma (NPC) undergoing intensity-modulated radiotherapy (IMRT) remains controversial. The present study compared the survival rates and radiation-induced optic neuropathy (RION) occurrence between T4 NPC patients whose …

cn (code pays fourni par la source)

2 citations Frontiers in Oncology
Accès ouvert 2021 article OpenAlex

Identification of a tumor microenvironment-associated prognostic gene signature in bladder cancer by integrated bioinformatic analysis.

Zhengchun Liu, Xiuli Liu, Rui Cai, Meilian Liu et autres

) were possible independent prognostic markers for patients with bladder cancer. Multiple gene set enrichment analysis of individual genes showed strong correlations with stromal and immune interactions, indicating that these nine genes may be related to carcinogenesis, invasion, and metastasis of bladder …

cn (code pays fourni par la source)

11 citations PubMed
Accès ouvert 2020 article OpenAlex

Development and validation of a novel stem cell subtype for bladder cancer based on stem genomic profiling

Chaozhi Tang, Jiakang Ma, Xiuli Liu, Zhengchun Liu

BACKGROUND: Bladder cancer (BLCA) is the fifth most common type of cancer worldwide, with high recurrence and progression rates. Although considerable progress has been made in the treatment of BLCA through accurate typing of molecular characteristics, little is known regarding the various …

cn (code pays fourni par la source)

28 citations Stem Cell Research & Therapy

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.